Analysts expect Orthopediatrics Corp (NASDAQ:KIDS) to report ($0.26) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Orthopediatrics’ earnings, with estimates ranging from ($0.35) to ($0.21). Orthopediatrics posted earnings per share of ($0.19) in the same quarter last year, which indicates a negative year-over-year growth rate of 36.8%. The company is scheduled to report its next quarterly earnings report on Wednesday, March 4th.
According to Zacks, analysts expect that Orthopediatrics will report full year earnings of ($0.86) per share for the current financial year, with EPS estimates ranging from ($0.93) to ($0.79). For the next fiscal year, analysts forecast that the business will post earnings of ($0.26) per share, with EPS estimates ranging from ($0.33) to ($0.11). Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Orthopediatrics.
Orthopediatrics (NASDAQ:KIDS) last announced its earnings results on Thursday, November 7th. The company reported ($0.18) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.01). The company had revenue of $20.74 million during the quarter, compared to the consensus estimate of $19.87 million. Orthopediatrics had a negative return on equity of 12.12% and a negative net margin of 15.80%. Orthopediatrics’s revenue for the quarter was up 31.1% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.15) earnings per share.
Several hedge funds have recently made changes to their positions in the company. Aperio Group LLC purchased a new position in shares of Orthopediatrics in the second quarter valued at about $39,000. Meadow Creek Investment Management LLC raised its stake in Orthopediatrics by 125.0% during the 2nd quarter. Meadow Creek Investment Management LLC now owns 2,160 shares of the company’s stock valued at $84,000 after purchasing an additional 1,200 shares during the period. Bank of Montreal Can raised its stake in Orthopediatrics by 56.3% during the 2nd quarter. Bank of Montreal Can now owns 2,853 shares of the company’s stock valued at $112,000 after purchasing an additional 1,028 shares during the period. Neuburgh Advisers LLC lifted its holdings in Orthopediatrics by 125.0% in the 2nd quarter. Neuburgh Advisers LLC now owns 2,970 shares of the company’s stock worth $116,000 after purchasing an additional 1,650 shares in the last quarter. Finally, Tyers Asset Management LLC lifted its holdings in Orthopediatrics by 125.0% in the 2nd quarter. Tyers Asset Management LLC now owns 3,780 shares of the company’s stock worth $148,000 after purchasing an additional 2,100 shares in the last quarter. Hedge funds and other institutional investors own 50.21% of the company’s stock.
NASDAQ:KIDS opened at $39.24 on Thursday. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.35 and a quick ratio of 1.61. The stock has a 50-day simple moving average of $38.06 and a two-hundred day simple moving average of $36.68. Orthopediatrics has a 52-week low of $27.20 and a 52-week high of $47.82.
Orthopediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Recommended Story: What is a Reverse Stock Split?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.